Managment of anaerobic infection

Expert Review of Anti-Infective Therapy

Volumn 2, Issue 1, 2004, Pages 153-158

  Brook, Itzhak ^a  

^a NONE   (United States)

Author keywords

Anaerobic; Antimicrobial; Carbapenum; Cephalosporin; Chloramphenicol; Clindamycin and lincomycin; Glycopeptide; Macrolide; Metronidazole; Penicillin; Quinolone; Tetracycline

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; BACITRACIN; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLAVULANIC ACID; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; IMIPENEM; MACROLIDE; METRONIDAZOLE; OXYGEN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TAZOBACTAM; TETRACYCLINE DERIVATIVE; TICARCILLIN; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL INFECTION; ANAEROBIC INFECTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; APLASTIC ANEMIA; ARTICLE; BACTEREMIA; BONE INFECTION; BRAIN INFECTION; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CONVALESCENCE; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG STABILITY; GRAM NEGATIVE BACTERIUM; HUMAN; HYPERBARIC OXYGEN; INFECTIOUS ARTHRITIS; LEUKOPENIA; LUNG INFECTION; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PENICILLIN RESISTANCE; PEPTOSTREPTOCOCCUS; SKIN INFECTION; SURGICAL TECHNIQUE; TOOTH INFECTION; TREATMENT PLANNING; UPPER RESPIRATORY TRACT INFECTION; ANAEROBIC BACTERIUM; ANIMAL; BACTERIAL INFECTION; CLINICAL TRIAL; MICROBIOLOGY; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; CLINICAL TRIALS; HUMANS; HYPERBARIC OXYGENATION;

EID: 2942624166     PISSN: 14787210     EISSN: None     Source Type: Journal    
DOI: 10.1586/14787210.2.1.153     Document Type: Article

References (8)

1. Finegold SM. Anaerobic Bacteria in Human disease. Academic Press Inc, FL, USA (1977).
2. Brook I. Pediatric anaerobic infections. Marcel Dekker, Inc., NY, USA (2002).
3. Snydman DR, Jacobus NV, McDermott LA et al. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob. Agents Chemother. 43, 2417-2422 (1999).
4. Sutter VL, Finegold SM. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob. Agents Chemother. 10, 736-752 (1976).
5. Brook I. The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev. Infect. Dis. 6, 601-607 (1984).
6. Hoellman DB, Kelly LM, Credito K et al In vitro anti-anaerobic activity of ertapenem (MK-0826) compared to seven other compounds. Antimicrob. Agents Chemother. 46, 220-224 (2002).
7. Goldstein EJ. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety. Clin. Infect. Dis. 23, S25-S30 (1996).
8. Saito T, Senda K, Takakura S et al. Anaerobic bacteremia: the yield of positive anaerobic blood cultures: patient characteristics and potential risk factors. Clin. Chem. Lab. Med. 41, 293-297 (2003).